ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
- 30 June 2008
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 60 (3), 401-407
- https://doi.org/10.1016/j.lungcan.2007.10.014
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- DNA Synthesis and Repair GenesRRM1andERCC1in Lung CancerNew England Journal of Medicine, 2007
- DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant ChemotherapyNew England Journal of Medicine, 2006
- Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- High Gene Expression of TS1, GSTP1, and ERCC1 Are Risk Factors for Survival in Patients Treated with Trimodality Therapy for Esophageal CancerClinical Cancer Research, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- ERCC1 and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil ChemotherapyJournal of Clinical Oncology, 2001
- Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapyCancer Treatment Reviews, 1998
- ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.Journal of Clinical Oncology, 1998
- Revisions in the International System for Staging Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1997
- ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1992